John H Johnson Insider Trading $MLNT MELINTA THERAPEUTICS, INC. /NEW/
Get free email notifications about insider trading for John H Johnson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John H Johnson. John H Johnson is CEO in IMCLONE SYSTEMS INC ($IMCLE) and Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in HISTOGENICS CORP ($HSGX) and Chief Executive Officer in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in CEMPRA, INC. ($CEMP) and Interim CEO in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in Verastem, Inc. ($VSTM) and Chief Executive Officer in Strongbridge Biopharma plc ($SBBP) and Director in Strongbridge Biopharma plc ($SBBP) and Executive Chairman in Strongbridge Biopharma plc ($SBBP).
John H Johnson in MELINTA THERAPEUTICS, INC. /NEW/
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John H Johnson: Chief Executive Officer, Interim CEO, Director
Holdings: 37,400 shares
Current Value: $112,200
Latest Transaction: Jul 02 2019
$MLNT Market Capitalization: $151.90M
$MLNT Previous Close: $3.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John H Johnson in MELINTA THERAPEUTICS, INC. /NEW/
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, IMCLE, MLNT, HSGX, PTLA, SBBP, SCMP, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 02 2019 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Chief Executive Off ... | Sell | S | 5.57 | 13,000 | 72,441 | 37,400 | 50.4 K to 37.4 K (-25.79 %) |
| Jun 26 2019 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Director | Option Exercise | M | 0.00 | 50,000 | 0 | 350,000 | |
| Jun 26 2019 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Director | Buy | M | 0.00 | 50,000 | 0 | 50,400 | 400 to 50.4 K (+12,500.00 %) |
| Feb 26 2019 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Chief Executive Off ... | Option Exercise | A | 0.00 | 400,000 | 0 | 400,000 | |
| Oct 29 2018 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Interim CEO | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Oct 29 2018 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Interim CEO | Option Exercise | A | 2.80 | 150,000 | 420,000 | 150,000 | |
| Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Director | Option Exercise | A | 7.45 | 9,100 | 67,795 | 9,100 | |
| Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | JOHNSON JOHN | Director | Option Exercise | A | 7.45 | 25,000 | 186,250 | 25,000 | |
| Jan 05 2017 | CEMP | CEMPRA, INC. | JOHNSON JOHN | Director | Option Exercise | A | 3.00 | 15,000 | 45,000 | 15,000 | |
| Jan 05 2016 | CEMP | CEMPRA, INC. | JOHNSON JOHN | Director | Option Exercise | A | 31.13 | 15,000 | 466,950 | 15,000 |
Page: 1